Literature DB >> 24769047

Systems biology and systems genetics - novel innovative approaches to study host-pathogen interactions during influenza infection.

Heike Kollmus1, Esther Wilk1, Klaus Schughart2.   

Abstract

Influenza represents a serious threat to public health with thousands of deaths each year. A deeper understanding of the host-pathogen interactions is urgently needed to evaluate individual and population risks for severe influenza disease and to identify new therapeutic targets. Here, we review recent progress in large scale omics technologies, systems genetics as well as new mathematical and computational developments that are now in place to apply a systems biology approach for a comprehensive description of the multidimensional host response to influenza infection. In addition, we describe how results from experimental animal models can be translated to humans, and we discuss some of the future challenges ahead.
Copyright © 2014 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24769047     DOI: 10.1016/j.coviro.2014.03.008

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  12 in total

1.  Childhood tolerance of severe influenza: a mortality analysis in mice.

Authors:  Freeman Suber; Lester Kobzik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-09-07       Impact factor: 5.464

2.  Host genetic diversity influences the severity of Pseudomonas aeruginosa pneumonia in the Collaborative Cross mice.

Authors:  Nicola Ivan Lorè; Fuad A Iraqi; Alessandra Bragonzi
Journal:  BMC Genet       Date:  2015-08-28       Impact factor: 2.797

Review 3.  Modeling Influenza Virus Infection: A Roadmap for Influenza Research.

Authors:  Alessandro Boianelli; Van Kinh Nguyen; Thomas Ebensen; Kai Schulze; Esther Wilk; Niharika Sharma; Sabine Stegemann-Koniszewski; Dunja Bruder; Franklin R Toapanta; Carlos A Guzmán; Michael Meyer-Hermann; Esteban A Hernandez-Vargas
Journal:  Viruses       Date:  2015-10-12       Impact factor: 5.048

4.  Respiratory Mucosal Proteome Quantification in Human Influenza Infections.

Authors:  Tony Marion; Husni Elbahesh; Paul G Thomas; John P DeVincenzo; Richard Webby; Klaus Schughart
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

5.  Influenza H3N2 infection of the collaborative cross founder strains reveals highly divergent host responses and identifies a unique phenotype in CAST/EiJ mice.

Authors:  Sarah R Leist; Carolin Pilzner; Judith M A van den Brand; Leonie Dengler; Robert Geffers; Thijs Kuiken; Rudi Balling; Heike Kollmus; Klaus Schughart
Journal:  BMC Genomics       Date:  2016-02-27       Impact factor: 3.969

Review 6.  Influenza-Omics and the Host Response: Recent Advances and Future Prospects.

Authors:  Joshua D Powell; Katrina M Waters
Journal:  Pathogens       Date:  2017-06-10

7.  Construction of a Transcriptome-Driven Network at the Early Stage of Infection with Influenza A H1N1 in Human Lung Alveolar Epithelial Cells.

Authors:  Myungguen Chung; Soo Young Cho; Young Seek Lee
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

8.  Of mice and men: the host response to influenza virus infection.

Authors:  Heike Kollmus; Carolin Pilzner; Sarah R Leist; Mark Heise; Robert Geffers; Klaus Schughart
Journal:  Mamm Genome       Date:  2018-06-15       Impact factor: 2.957

9.  RNAseq expression analysis of resistant and susceptible mice after influenza A virus infection identifies novel genes associated with virus replication and important for host resistance to infection.

Authors:  Esther Wilk; Ashutosh K Pandey; Sarah Rebecca Leist; Bastian Hatesuer; Matthias Preusse; Claudia Pommerenke; Junxi Wang; Klaus Schughart
Journal:  BMC Genomics       Date:  2015-09-02       Impact factor: 3.969

10.  Genetically diverse CC-founder mouse strains replicate the human influenza gene expression signature.

Authors:  Husni Elbahesh; Klaus Schughart
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.